ACTEOS (EOS.PA) Fundamental Analysis & Valuation

EPA:EOS • FR0000076861

Current stock price

0.854 EUR
+0 (+0.47%)
Last:

This EOS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EOS.PA Profitability Analysis

1.1 Basic Checks

  • EOS had negative earnings in the past year.
  • EOS had a negative operating cash flow in the past year.
  • In the past 5 years EOS reported 4 times negative net income.
  • EOS had a positive operating cash flow in 4 of the past 5 years.
EOS.PA Yearly Net Income VS EBIT VS OCF VS FCFEOS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

  • The Return On Assets of EOS (-17.36%) is worse than 80.91% of its industry peers.
Industry RankSector Rank
ROA -17.36%
ROE N/A
ROIC N/A
ROA(3y)-4.8%
ROA(5y)-3.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EOS.PA Yearly ROA, ROE, ROICEOS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 40.86%, EOS is doing worse than 71.82% of the companies in the same industry.
  • EOS's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for EOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
EOS.PA Yearly Profit, Operating, Gross MarginsEOS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1

2. EOS.PA Health Analysis

2.1 Basic Checks

  • EOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EOS has less shares outstanding
  • Compared to 5 years ago, EOS has about the same amount of shares outstanding.
  • Compared to 1 year ago, EOS has a worse debt to assets ratio.
EOS.PA Yearly Shares OutstandingEOS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EOS.PA Yearly Total Debt VS Total AssetsEOS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -0.18, we must say that EOS is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.18, EOS is not doing good in the industry: 80.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.18
ROIC/WACCN/A
WACC7.77%
EOS.PA Yearly LT Debt VS Equity VS FCFEOS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 0.68 indicates that EOS may have some problems paying its short term obligations.
  • With a Current ratio value of 0.68, EOS is not doing good in the industry: 89.09% of the companies in the same industry are doing better.
  • EOS has a Quick Ratio of 0.68. This is a bad value and indicates that EOS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of EOS (0.68) is worse than 88.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
EOS.PA Yearly Current Assets VS Current LiabilitesEOS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

0

3. EOS.PA Growth Analysis

3.1 Past

  • The earnings per share for EOS have decreased strongly by -381.75% in the last year.
  • The Revenue for EOS has decreased by -34.48% in the past year. This is quite bad
  • Measured over the past years, EOS shows a decrease in Revenue. The Revenue has been decreasing by -1.69% on average per year.
EPS 1Y (TTM)-381.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.61%
Revenue 1Y (TTM)-34.48%
Revenue growth 3Y0.21%
Revenue growth 5Y-1.69%
Sales Q2Q%-43.85%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EOS.PA Yearly Revenue VS EstimatesEOS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1

4. EOS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • EOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EOS.PA Price Earnings VS Forward Price EarningsEOS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EOS is valued cheaply inside the industry as 84.55% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.81
EOS.PA Per share dataEOS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. EOS.PA Dividend Analysis

5.1 Amount

  • EOS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EOS.PA Fundamentals: All Metrics, Ratios and Statistics

ACTEOS

EPA:EOS (4/10/2026, 7:00:00 PM)

0.854

+0 (+0.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.86M
Revenue(TTM)9.81M
Net Income(TTM)-1.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 7.81
EPS(TTM)-0.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS2.93
BVpS-0.77
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.86%
FCFM N/A
ROA(3y)-4.8%
ROA(5y)-3.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score3
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 3.6
Cap/Depr 159.88%
Cap/Sales 23.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z -0.18
F-Score3
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)120.97%
Cap/Depr(5y)100.16%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.48%
Revenue growth 3Y0.21%
Revenue growth 5Y-1.69%
Sales Q2Q%-43.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-211.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41050.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-130.13%
OCF growth 3Y-17.91%
OCF growth 5YN/A

ACTEOS / EOS.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ACTEOS?

ChartMill assigns a fundamental rating of 1 / 10 to EOS.PA.


Can you provide the valuation status for ACTEOS?

ChartMill assigns a valuation rating of 1 / 10 to ACTEOS (EOS.PA). This can be considered as Overvalued.


Can you provide the profitability details for ACTEOS?

ACTEOS (EOS.PA) has a profitability rating of 1 / 10.